Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of JY09

Clinical trial NCT04354090 · COMPLETED

Trial details

NCT number: NCT04354090
Sponsor: Beijing Dongfang Biotech Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2018-04-26
Primary completion: 2018-12-27
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.